PHARMING GROUP NV (PHARM.AS)

NL0010391025 - Common Stock

0.881  -0.02 (-2.6%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
245.32M205.62M198.87M212.17M179.25M
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
25.21M17.56M21.14M23.54M22.65M
Gross Profit
220.10M188.06M177.73M188.63M156.60M
Operating Expenses
241.85M177.69M153.73M112.38M92.01M
Research and Development
66.81M50.87M62.09M35.68M30.08M
Selling, General, and Administrative Expenses
166.11M120.29M85.09M70.44M62.39M
Operating Income
-21.75M10.37M24.00M76.26M64.59M
Interest Income/Expense
-6.63M-3.25M9.52M-28.42M-12.03M
Other Income/Expense
N/AN/A0.00-3.74M-3.06M
Non Recurring Items
16.36M7.87M-10.44M0.00-770.00K
Income Before Taxes
-12.01M14.99M23.08M44.09M49.50M
Income Tax
-1.46M1.31M7.08M6.35M11.12M
Net Income
-10.55M13.67M16.00M37.75M38.38M
EBITDA
-5.83M23.55M43.61M84.57M70.08M
 
Per Share Data
EPS Diluted Total Ops
-0.020.020.020.060.06
Non GAAP EPS
-0.02N/A0.020.050.06
 
Statistics
Gross Profit Margin
89.72%91.46%89.37%88.91%87.37%
Profit Margin
-4.30%6.65%8.04%17.79%21.41%
Operating Profit Margin
-8.87%5.04%12.07%35.94%36.03%

All data in USD

Charts